Flagellin Restricts HIV-1 Infection of Macrophages through Modulation of Viral Entry Receptors and CC Chemokines

Lina Zhou1, Xu Wang1, Qianhao Xiao1

  • 1Department of Pathology and Laboratory Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, PA 19140, USA.

Viruses
|July 27, 2024
PubMed

Insights

Flagellins from bacteria inhibit HIV-1 infection in human macrophages by reducing viral entry receptors and increasing protective chemokines. This interaction involves toll-like receptor 5 (TLR5), suggesting potential for flagellin-based vaccine adjuvants.

Area of Science:

  • Immunology
  • Virology
  • Microbiology

Background:

  • Flagellin, a bacterial protein, and macrophages play roles in HIV-1 infection.
  • The specific impact of flagellin-macrophage interaction on HIV-1 pathogenesis is not fully understood.

Purpose of the Study:

  • To investigate the effect of flagellins on HIV-1 infection in primary human macrophages.
  • To elucidate the underlying mechanisms of flagellin-mediated modulation of HIV-1 infection.

Main Methods:

  • Macrophages were pretreated with flagellins from different bacteria.
  • HIV-1 infection levels were assessed.
  • Expression of HIV-1 entry receptors (CD4, CCR5) and CC chemokines (MIP-1α, MIP-1β, RANTES) was analyzed.
  • The role of toll-like receptor 5 (TLR5) was examined using an antagonist.

Main Results:

  • Flagellin pretreatment significantly inhibited HIV-1 infection in macrophages.
  • Flagellin treatment downregulated CD4 and CCR5 expression.
  • Flagellin treatment upregulated CC chemokines MIP-1α, MIP-1β, and RANTES.
  • The observed effects were dependent on TLR5 activation, as shown by antagonism.

Conclusions:

  • Flagellins inhibit HIV-1 infection of macrophages through TLR5-mediated downregulation of entry receptors and upregulation of antiviral chemokines.
  • Flagellin-TLR5 interactions represent a potential target for enhancing innate immunity against HIV-1.
  • Further research is needed to explore flagellin adjuvant-based vaccine strategies for HIV-1 prevention.